Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20,104
Closed -$2.42M 117
2025
Q2
$2.42M Buy
20,104
+207
+1% +$25K 0.69% 44
2025
Q1
$2.32M Buy
19,897
+889
+5% +$108K 0.72% 43
2024
Q4
$2.28M Sell
19,008
-1,494
-7% -$180K 0.73% 43
2024
Q3
$2.18M Buy
20,502
+725
+4% +$71.8K 0.71% 44
2024
Q2
$1.87M Sell
19,777
-290
-1% -$30.1K 0.63% 43
2024
Q1
$2.22M Sell
20,067
-707
-3% -$66K 0.76% 41
2023
Q4
$1.8M Buy
20,774
+428
+2% +$32.4K 0.69% 42
2023
Q3
$1.43M Buy
+20,346
New +$1.42M 0.58% 47

Other funds holding ESAB

Shilanski & Associates's ESAB Position: Q3 2025 in Review

Shilanski & Associates sold out of ESAB (ESAB) in Q3 2025, closing a stake of 20,104 shares — an estimated $2.42M sold.

Shilanski & Associates first reported a position in ESAB in Q3 2023 and held it in 8 quarters. The position peaked at $2.42M in Q2 2025. 362 funds tracked by Wall St. Rank hold ESAB as of Q3 2025.

  • Shilanski & Associates reported no remaining ESAB position as of Q3 2025 after selling out during the quarter.
  • Shilanski & Associates sold 20,104 ESAB shares in Q3 2025, an estimated $2.42M.
  • Shilanski & Associates first reported a position in ESAB in Q3 2023 and held it in 8 quarters.
  • Shilanski & Associates's ESAB position peaked at $2.42M in Q2 2025.
  • 362 funds tracked by Wall St. Rank held ESAB as of Q3 2025.

Based on Shilanski & Associates's 13F filing for Q3 2025, filed 20 Oct 2025.